WahanaRiau.com - Revolution medicines

Berita Politik Peristiwa Ekonomi Otomotif Olahraga Teknologi Gaya Hidup Travel Video Media OutReach Globenewswire Advertorial Pilihan Editor Terpopuler Indeks

Berita
Peristiwa
Politik
Ekonomi
Teknologi
Otomotif
Olahraga
Gaya Hidup
Travel
More

Revolution medicines

Index

Globenewswire

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Selasa, 07 Juli 2026 - 21:50:47 Wib

Globenewswire

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Senin, 13 April 2026 - 22:34:55 Wib

Revolution medicines

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Terpopuler

Green SM Wins Double Honors at the HR Asia Awards 2026
Dibaca: 101 Kali

Hong Kong Named Exclusive Asian Host of Middle East’s Flagship Tech Expo “LEAP East” for the Next Three Years
Dibaca: 243 Kali

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era
Dibaca: 139 Kali

Dmitry Shubov Consulting Issues Cross-Border Advisory on U.S. Vendor Contract Risks for Southeast Asian Founders
Dibaca: 118 Kali

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Dibaca: 133 Kali

Terkini

Green SM Wins Double Honors at the HR Asia Awards 2026

Hong Kong Named Exclusive Asian Host of Middle East’s Flagship Tech Expo “LEAP East” for the Next Three Years

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era

Dmitry Shubov Consulting Issues Cross-Border Advisory on U.S. Vendor Contract Risks for Southeast Asian Founders

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

Revolution medicines

European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process

Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer

Terpopuler

Green SM Wins Double Honors at the HR Asia Awards 2026 Dibaca: 101 Kali

Hong Kong Named Exclusive Asian Host of Middle East’s Flagship Tech Expo “LEAP East” for the Next Three Years Dibaca: 243 Kali

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era Dibaca: 139 Kali

Dmitry Shubov Consulting Issues Cross-Border Advisory on U.S. Vendor Contract Risks for Southeast Asian Founders Dibaca: 118 Kali

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling Dibaca: 133 Kali

Terkini

Green SM Wins Double Honors at the HR Asia Awards 2026

Hong Kong Named Exclusive Asian Host of Middle East’s Flagship Tech Expo “LEAP East” for the Next Three Years

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era

Dmitry Shubov Consulting Issues Cross-Border Advisory on U.S. Vendor Contract Risks for Southeast Asian Founders

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling

Green SM Wins Double Honors at the HR Asia Awards 2026
Dibaca: 101 Kali

Hong Kong Named Exclusive Asian Host of Middle East’s Flagship Tech Expo “LEAP East” for the Next Three Years
Dibaca: 243 Kali

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era
Dibaca: 139 Kali

Dmitry Shubov Consulting Issues Cross-Border Advisory on U.S. Vendor Contract Risks for Southeast Asian Founders
Dibaca: 118 Kali

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling
Dibaca: 133 Kali